These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Lee JM; Kim CS; Youk JH; Lee MS Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629 [TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging. Hamm B; Fischer E; Taupitz M J Comput Assist Tomogr; 1990; 14(2):205-16. PubMed ID: 2312848 [TBL] [Abstract][Full Text] [Related]
20. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. Yamashita Y; Fan ZM; Yamamoto H; Matsukawa T; Yoshimatsu S; Miyazaki T; Sumi M; Harada M; Takahashi M J Magn Reson Imaging; 1994; 4(1):83-90. PubMed ID: 8148562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]